BARCLAYS PLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 62 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$470.0%18,406
+39.0%
0.00%
Q2 2023$47
+4.4%
13,239
-35.9%
0.00%
Q1 2023$45
-90.6%
20,649
-48.1%
0.00%
Q4 2022$478
-99.7%
39,778
+84.6%
0.00%
Q3 2022$140,000
+55.6%
21,543
+8.7%
0.00%
Q2 2022$90,000
-60.4%
19,819
-24.7%
0.00%
Q1 2022$227,000
-85.5%
26,329
-76.0%
0.00%
Q4 2021$1,566,000
+128.6%
109,764
+252.5%
0.00%
Q3 2021$685,000
+40.4%
31,142
-14.6%
0.00%
Q2 2021$488,000
+134.6%
36,481
+78.1%
0.00%
Q1 2021$208,000
+1200.0%
20,483
+435.8%
0.00%
Q4 2020$16,000
+60.0%
3,8230.0%0.00%
Q3 2020$10,000
-23.1%
3,8230.0%0.00%
Q2 2020$13,000
+8.3%
3,8230.0%0.00%
Q1 2020$12,000
-40.0%
3,8230.0%0.00%
Q4 2019$20,000
-84.7%
3,823
-90.7%
0.00%
Q3 2019$131,000
-11.5%
41,198
+0.0%
0.00%
Q2 2019$148,000
-1.3%
41,1860.0%0.00%
Q1 2019$150,000
+21.0%
41,1860.0%0.00%
Q4 2018$124,000
-38.3%
41,1860.0%0.00%
Q3 2018$201,000
-34.3%
41,1860.0%0.00%
Q2 2018$306,000
+14.2%
41,1860.0%0.00%
Q1 2018$268,000
-27.8%
41,1860.0%0.00%
Q4 2017$371,000
-9.3%
41,1860.0%0.00%
Q3 2017$409,000
+75.5%
41,186
+37.6%
0.00%
Q2 2017$233,000
+26.6%
29,9250.0%0.00%
Q1 2017$184,000
+0.5%
29,9250.0%0.00%
Q4 2016$183,000
-15.7%
29,9250.0%0.00%
Q3 2016$217,000
-13.2%
29,9250.0%0.00%
Q2 2016$250,000
+38.9%
29,9250.0%0.00%
Q1 2016$180,000
-24.7%
29,9250.0%0.00%
Q4 2015$239,000
+97.5%
29,925
+172.3%
0.00%
Q1 2014$121,00010,9890.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders